• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
SONG Lin, WANG Mao, WEN Aidong, YANG Lin, JIA Yuntao, XIE Huiru, JIANG Xuehua, WANG Ling. Determination of agomelatine in human plasma by LC-MS/MS:application to a pharmacokinetic study in Chinese volunteers[J]. Journal of China Pharmaceutical University, 2014, 45(6): 698-702. DOI: 10.11665/j.issn.1000-5048.20140615
Citation: SONG Lin, WANG Mao, WEN Aidong, YANG Lin, JIA Yuntao, XIE Huiru, JIANG Xuehua, WANG Ling. Determination of agomelatine in human plasma by LC-MS/MS:application to a pharmacokinetic study in Chinese volunteers[J]. Journal of China Pharmaceutical University, 2014, 45(6): 698-702. DOI: 10.11665/j.issn.1000-5048.20140615
shu

Determination of agomelatine in human plasma by LC-MS/MS:application to a pharmacokinetic study in Chinese volunteers

More Information
    Graphical Abstract
    • Abstract
  • To establish an LC-MS/MS method for the determination of agomelatine in human plasma and to study the pharmacokinetics in Chinese healthy volunteers following oral administration of agomelatine tablets. 72 volunteers were administered with single oral dose of 25 mg of agomelatine. The plasma concentration of agomelatine was determined by LC-MS/MS. The pharmacokinetic parameters were calculated by Phoenix WinNonlin 6. 3. 0. The calibration curve of agomelatine was linear over the range of 0. 051 3-10. 38 ng/mL(r=0. 999 4). The lower limit of quantification of agomelatine was 0. 051 3 ng/mL. Both intra- and inter-day RSD were less than 15%. The main pharmacokinetic parameters were as follows: cmax was(13. 25±15. 78)ng/mL; tmax was(0. 68±0. 41)h; AUClast was(14. 00±19. 26)ng/mL ·h; AUCinf was(14. 14±19. 35)ng/mL ·h and t1/2 was(0. 78±0. 44)h. The LC/MS/MS method was convenient, precise and reproducible. It can be used for the determination of agomelatine in human plasma and its clinical pharmacokinetic studies.
    • FullText(HTML)
    • References (10)
  • [1]
    Wang X, Ma HM, Zhou YS. The graphical synthetic routes of agomelatine[J].Chin J Med Chem(中国药物化学杂志),2012,99(4):334-336.
    [2]
    Landolt HP,Wehrle R.Antagonism of serotonergic 5-HT2A/2C receptors:mutual improvement of sleep,cognition and mood[J].Eur J Neurosci,2009,29(9):1 795-1 809.
    [3]
    Howland RH.Critical appraisal and update on the clinical utility of agomelatine,a melatonergic agonist,for the treatment of major depressive disease in adults[J].Neuropsychiatr Dis Treat,2009,5:563-576.
    [4]
    Millan M,Gobert A,Lejeune F,et al.The novel melatonin agonist agomelatine(S20098)is an antagonist at 5-hydroxytryptamine 2C receptors,blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways[J].J Pharmacol Exp Ther,2003,306(3):954-964.
    [5]
    Banasr M,Soumier A,Hery M,et al.Agomelatine,a new antidepressant,induces regional changes in hippocampal neurogenesis[J].Biol Psychiatry,2006,59(11):1 087-1 096.
    [6]
    Wei MJ,Zhang ZF,Zhang ZF.Discussion on accuracy in the analysis of biological samples and improvement measures[EB/OL].(2012-04-11)[2012-09-30] .http://www.cde.org.cn/dzkw.do?method=largePage&id=312642.
    [7]
    European Medicines Agency. CHMP ASSESSMENT REPORT FOR Valdoxan[EB/OL].(2008-11-20)[2011-12-12] .http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000915/WC500046226.pdf.
    [8]
    European Medicines Agency.Guideline on the investigation of bioequivalence[EB/OL].(2010-01-20)[2011-12-12] .http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.
    [9]
    Chow SC,Liu J.Design and Analysis of Bioavailability and Bioequivalence Studies[M].CRC Press,2000.
    [10]
    Patil SR,Nerurkar KK,Kalamkar AM,et al.Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study[J].J Mass Spectrom,2012,47(1):23-28.
    • Related Articles

  • Related Articles

    [1]SHI Wenxing, LYU Qing, QU Guiwu, ZHAO Ying, ZHOU Fengmei. Therapeutic effect and mechanism of sodium formononetin-3′-sulphonate on collagen-induced rheumatoid arthritis[J]. Journal of China Pharmaceutical University, 2021, 52(5): 579-585. DOI: 10.11665/j.issn.1000-5048.20210510
    [2]LIN Xiaobing, WANG Hao, ZHANG Junhan, LIN Zihao, YAN Ming, AN Xiaofei. Screening of prostaglandin E2 receptor 4 antagonist from active compounds of Baeckea frutescens L. and its anti-rheumatoid arthritis effect in vivo[J]. Journal of China Pharmaceutical University, 2021, 52(1): 92-99. DOI: 10.11665/j.issn.1000-5048.20210113
    [3]ZHANG Ting, LIAO Hang, CHENG Yuting, WU Xiaohong. Preparation and properties of injectable minocycline hydrochloride microsphere depot[J]. Journal of China Pharmaceutical University, 2021, 52(1): 52-59. DOI: 10.11665/j.issn.1000-5048.20210107
    [4]LIU Bowen, LIU Fulei, WANG Ruyi, XUE Jingwei, LIU Wenyuan, FENG Feng, QU Wei. Chemical constituents of total alkaloids from Picrasma quassioides and its effects on collagen induced arthritis in rats[J]. Journal of China Pharmaceutical University, 2019, 50(5): 585-592. DOI: 10.11665/j.issn.1000-5048.20190512
    [5]WANG Chen, HUANG Xin, JIANG Zhenzhou, ZHANG Luyong. Advances in the role of steroids in rheumatoid arthritis[J]. Journal of China Pharmaceutical University, 2015, 46(6): 757-763. DOI: 10.11665/j.issn.1000-5048.20150621
    [6]WU Qi, WU Qian, LUO Xun. Effects of Cynanchum paniculatum paeonol on apoptosis of articular chondrocyte in rabbits with knee osteoarthritis[J]. Journal of China Pharmaceutical University, 2015, 46(3): 359-363. DOI: 10.11665/j.issn.1000-5048.20150317
    [7]LI Pei, WANG Da-wei, LIU Xiao-dong. Tumor necrosis factor-αand its receptors in rheumatoid arthritis[J]. Journal of China Pharmaceutical University, 2011, 42(3): 276-283.
    [8]JING Li-juan, WANG Mei-mei. Relationship between RANKL/OPG system and typeⅡcollagen-induced arthritis in rats and the intervention of [99Tc]-methylene diphosphonate[J]. Journal of China Pharmaceutical University, 2011, 42(3): 251-254.
    [10]Effect of Tripterygium wilfordii PAP Patcher(TWPP) on Adjuvant Arthritis in Rats[J]. Journal of China Pharmaceutical University, 1995, (4): 223-225.

  • Cited by

    Periodical cited type(3)

    1. 杜泽飞，张国文，孙健玮. 重楼中皂苷类成分抗肿瘤作用及机制研究进展. 云南医药. 2024(02): 73-75 .
    2. 刘天会. 细胞器之间相互作用在非酒精性脂肪性肝病发生发展中的作用. 临床肝胆病杂志. 2023(01): 181-187 .
    3. 曹守莹. 新型吡啶氮唑氮芥化合物与线粒体的作用及其抗肿瘤活性. 湖北理工学院学报. 2021(01): 56-61 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML
    Article views (1414) PDF downloads (1259) Cited by(9)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365731

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return